95 related articles for article (PubMed ID: 21778905)
1. Mixed connective tissue disease with protein-losing enteropathy: discussion of the treatment strategy.
Chao CT; Lai CY; Chang PL; Wu HS; Wu VC; Wang WJ
J Clin Rheumatol; 2011 Aug; 17(5):286-7. PubMed ID: 21778905
[No Abstract] [Full Text] [Related]
2. [A case of protein-losing gastroenteropathy in association with mixed connective tissue disease which was successfully treated with cyclophosphamide pulse therapy].
Nosho K; Takahashi H; Ikeda Y; Hanai Y; Mizukoshi T; Murakami R; Tokunou T; Kawahito Y; Makiguchi Y; Imai K; Inomata S; Saito T; Ikeda T
Ryumachi; 1998 Dec; 38(6):818-24. PubMed ID: 10047720
[TBL] [Abstract][Full Text] [Related]
3. Mixed connective tissue disease associated with protein losing enteropathy: successful treatment with intravenous cyclophosphamide therapy.
Furuya T; Suzuki T; Onoda N; Tamura K; Sato K; Demura H; Kashiwazaki S
Intern Med; 1992 Dec; 31(12):1359-62. PubMed ID: 1300171
[TBL] [Abstract][Full Text] [Related]
4. A case of systemic lupus erythematosus presenting with protein-losing enteropathy.
Türkçapar N; Ozyüncü N; Cinar K; Ensari A; Küçük O; Idilman R; Duman N; Ozden A
Turk J Gastroenterol; 2006 Sep; 17(3):226-30. PubMed ID: 16941261
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.
Bérezné A; Ranque B; Valeyre D; Brauner M; Allanore Y; Launay D; Le Guern V; Kahn JE; Couderc LJ; Constans J; Cohen P; Mahr A; Pagnoux C; Hachulla E; Kahan A; Cabane J; Guillevin L; Mouthon L
J Rheumatol; 2008 Jun; 35(6):1064-72. PubMed ID: 18464307
[TBL] [Abstract][Full Text] [Related]
6. Painless ascites and elevated CA125: initial presentation of lupus-associated protein-losing enteropathy.
Ong CS; Cheah TE; Jasmin R; Yahya F; Sockalingam S; Ng CT
Lupus; 2013 Oct; 22(11):1174-7. PubMed ID: 23886639
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic vignette: old and new drugs in mixed connective tissue disease.
Rozenbaum M; Slobodin G; Boulman N; Feld J; Avshovich N; Ben-Arieh Y; Rosner I
Isr Med Assoc J; 2008 Nov; 10(11):831-2. PubMed ID: 19070300
[No Abstract] [Full Text] [Related]
8. Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine.
Mok CC; Ying KY; Mak A; To CH; Szeto ML
Rheumatology (Oxford); 2006 Apr; 45(4):425-9. PubMed ID: 16234272
[TBL] [Abstract][Full Text] [Related]
9. Reversal of protein-losing enteropathy with heparin therapy in an adult patient with congenital heart disease.
Tsuzuki T; Okada H; Takenaka R; Kawahara Y; Kato J; Okazaki H; Kawamoto H; Shiratori Y
Digestion; 2006; 74(3-4):206-7. PubMed ID: 17341854
[No Abstract] [Full Text] [Related]
10. Trigeminal neuralgia as the first manifestation of mixed connective tissue disorder.
Hojaili B; Barland P
J Clin Rheumatol; 2006 Jun; 12(3):145-7. PubMed ID: 16755246
[TBL] [Abstract][Full Text] [Related]
11. Recalcitrant leg ulcer due to mixed connective tissue disease.
Rozin AP; Braun-Moscovici Y; Bergman R; Balbir-Gurman A
Neth J Med; 2006 Mar; 64(3):91-4. PubMed ID: 16547364
[TBL] [Abstract][Full Text] [Related]
12. Failure of steroid and immunosuppressant therapy to halt progression of mixed connective tissue disease.
Hendra TJ
Br J Clin Pract; 1988 Jun; 42(6):256-7. PubMed ID: 3207593
[No Abstract] [Full Text] [Related]
13. Protein-losing enteropathy and mixed connective-tissue disease.
Terren P
Med J Aust; 1988 Nov; 149(10):558-9. PubMed ID: 3185326
[TBL] [Abstract][Full Text] [Related]
14. Comment on: a case of Raynaud's phenomenon in mixed connective tissue disease responding to Rituximab therapy response.
Dunkley L; Green M; Gough A
Rheumatology (Oxford); 2007 Oct; 46(10):1628-9. PubMed ID: 17766999
[No Abstract] [Full Text] [Related]
15. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
[TBL] [Abstract][Full Text] [Related]
16. [Comparative effectiveness and combined administration of basic drugs in rheumatoid arthritis].
Noskov SM; Kozlov GS
Revmatologiia (Mosk); 1991; (1):26-9. PubMed ID: 1676853
[No Abstract] [Full Text] [Related]
17. A case of Raynaud's phenomenon in mixed connective tissue disease responding to rituximab therapy.
Haroon M; O'Gradaigh D; Foley-Nolan D
Rheumatology (Oxford); 2007 Apr; 46(4):718-9. PubMed ID: 17289791
[No Abstract] [Full Text] [Related]
18. Using heparin therapy to reverse protein-losing enteropathy in a patient with CDG-Ib.
Liem YS; Bode L; Freeze HH; Leebeek FW; Zandbergen AA; Paul Wilson J
Nat Clin Pract Gastroenterol Hepatol; 2008 Apr; 5(4):220-4. PubMed ID: 18285818
[TBL] [Abstract][Full Text] [Related]
19. A case of undifferentiated connective tissue disease: is it a distinct clinical entity?
Mosca M; Tani C; Bombardieri S
Nat Clin Pract Rheumatol; 2008 Jun; 4(6):328-32. PubMed ID: 18414458
[TBL] [Abstract][Full Text] [Related]
20. Retinal Vasculitis and Choroidopathy in Pediatric-Onset Mixed Connective Tissue Disease.
Postlethwaite B; Wynn HG; Pattanaik D; Ost S; MacDonald CB; Walton RC; Kim S; Myers LK; Brown Lobbins M
J Clin Rheumatol; 2017 Oct; 23(7):400-401. PubMed ID: 28937479
[No Abstract] [Full Text] [Related]
[Next] [New Search]
